| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00726869 Details | 2012-08-23 Interventional | 1 | 28 | Elotuzumab Multiple Myelom… Neoplasms, Plas… | Enrollment has been halted - | |||
| NCT01416961 Details | 2012-08-22 Interventional | 1 | 0 | Cisplatin Etoposide Etoposide phosp… Lung Neoplasms Lung Cancer | Neutron therapy has become unavailable - | |||
| NCT01035346 Details | 2012-08-21 Interventional | 3 | 16 | Ibuprofen Communicable Di… Infections Infection | - Definitive conclusion could not be made due to early termination of study, due to low enrollment rate, and small number of enrolled participants. | |||
| NCT00015847 Details | 2012-08-20 Interventional | 2 | 25 | Imatinib Mesyla… Interferon-alph… Interferons Leukemia Leukemia, Myelo… Leukemia, Myelo… | - Early termination; 12 month follow-up was not carried out. | |||
| NCT01206907 Details | 2012-08-17 Interventional | 3 | 0 | Oxymorphone Chronic Pain | The study is no longer required for the PREA for this product. - | |||
| NCT01096095 Details | 2012-08-17 Interventional | 2 | 0 | 4-phenylbutyric… Ataxia Cerebellar Atax… Machado-Joseph … Spinocerebellar… Spinocerebellar… Spinocerebellar… | Regulatory authorities did not allow the entrance of the study drug in the country - | |||
| NCT00385554 Details | 2012-08-16 Interventional | 1 | 0 | UC-781 HIV Infections | Study product is no longer being considered for further development. - | |||
| NCT01563601 2011-005591-41 Details | 2012-08-15 Interventional | 3 | 0 | Carboplatin Etoposide Etoposide phosp… Obatoclax Lung Neoplasms Small Cell Lung… Extensive-stage… | Business Decision - | |||
| NCT00929162 Details | 2012-08-07 Interventional | 2 | 120 | Carboplatin Paclitaxel Carcinoma, Ovar… Hypersensitivit… Ovarian Neoplas… Patients With A… | Primary objective of the trial was not met and so there was no benefit in collecting further
information - | |||
| NCT00658333 Details | 2012-08-07 Interventional | 4 | 30 | Mycophenolic Ac… Renal Transplan… | - Due to the insufficient number of patients enrolled in the study, no conclusions can be made from the data. | |||
| NCT00427583 Details | 2012-08-07 Interventional | 2/3 | 11 | Imatinib Mesyla… Nerve Sheath Ne… Neurofibrosarco… Malignant Perip… | stopped due to slow recruitment and no effect - | |||
| NCT00409331 Details | 2012-08-07 Interventional | 2 | 3 | Amifostine Head and Neck N… Head and Neck C… | Study terminated by Principal Investigator; no patients completed study. - | |||
| NCT00108433 Details | 2012-08-07 Interventional | 3 | 61 | Cefazolin Linezolid Vancomycin Bacteremia Bacterial Infec… Communicable Di… Gram-Positive B… Infections Sepsis | See Detailed Description Efficacy results were not reported because the study was prematurely terminated. | |||
| NCT01352026 Details | 2012-08-06 Interventional | 2 | 0 | Metformin Familial Primar… Hypertension Pulmonary Arter… | Several therapeutic have been developed making more difficult the eligibility of patients -
Recruitment of new centers wasn't possible due to competing trials - | |||
| NCT01274247 Details | 2012-08-02 Interventional | 1/2 | 21 | Benzocaine Ankyloglossia Maternal Nipple… Neonatal Latch … Neonatal Tongue… | The study ethics committee recommended concluding the study for longer crying time with
benzocaine and very short crying time in all participants. - | |||
| NCT01270893 Details | 2012-08-02 Interventional | 2 | 0 | Nilotinib Gastrointestina… Gastrointestina… Gastrointestina… | No particapnt recruitment. - | |||
| NCT00324142 Details | 2012-08-02 Interventional | 2 | 0 | Tinidazole Recurrence Vaginal Disease… Vaginosis, Bact… Recurrent Bacte… | Study Terminated Prematurely - | |||
| NCT00976027 Details | 2012-08-01 Interventional | 3 | 9172 | Vaccines Influenza, Huma… Influenza | No safety concerns, study terminated due to lack of primary endpoint cases in 2009-2010 Flu
season (coincided with H1N1 Pandemic) Subjects followed per-protocol The study was terminated due to lack of primary endpoint cases in 2009-2010 influenza season (coincided with the H1N1 Pandemic). There were no safety concerns; enrolled subjects were followed per-protocol. | |||
| NCT00800566 Details | 2012-08-01 Interventional | 1 | 0 | Clofarabine Leukemia Leukemia, Lymph… Leukemia, Lymph… Chronic Lymphoc… | Sponsor terminated. - | |||
| NCT00529282 Details | 2012-08-01 Interventional | 3 | 2 | Cefepime Ceftobiprole Ceftobiprole me… Vancomycin Bacterial Infec… Communicable Di… Fever Gram-Positive B… Infections Neutropenia Pseudomonas Inf… Gram-positive B… Pseudomonas Inf… | Study discontinued due to administrative reasons unrelated to safety No analysis was performed due to early termination of the study. |